BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 28940845)

  • 1. Emerging roles of syndecan 2 in epithelial and mesenchymal cancer progression.
    Mytilinaiou M; Nikitovic D; Berdiaki A; Kostouras A; Papoutsidakis A; Tsatsakis AM; Tzanakakis GN
    IUBMB Life; 2017 Nov; 69(11):824-833. PubMed ID: 28940845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGF-I regulates HT1080 fibrosarcoma cell migration through a syndecan-2/Erk/ezrin signaling axis.
    Mytilinaiou M; Nikitovic D; Berdiaki A; Papoutsidakis A; Papachristou DJ; Tsatsakis A; Tzanakakis GN
    Exp Cell Res; 2017 Dec; 361(1):9-18. PubMed ID: 28962916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell surface heparan sulfate proteoglycans control adhesion and invasion of breast carcinoma cells.
    Lim HC; Multhaupt HA; Couchman JR
    Mol Cancer; 2015 Jan; 14(1):15. PubMed ID: 25623282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shed syndecan-2 enhances tumorigenic activities of colon cancer cells.
    Choi S; Choi Y; Jun E; Kim IS; Kim SE; Jung SA; Oh ES
    Oncotarget; 2015 Feb; 6(6):3874-86. PubMed ID: 25686828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and prognostic role of syndecan-2 in prostate cancer.
    Popović A; Demirović A; Spajić B; Stimac G; Kruslin B; Tomas D
    Prostate Cancer Prostatic Dis; 2010 Mar; 13(1):78-82. PubMed ID: 19786981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Wnt signaling represses the proapoptotic proteoglycan syndecan-2 in osteosarcoma cells.
    Dieudonné FX; Marion A; Haÿ E; Marie PJ; Modrowski D
    Cancer Res; 2010 Jul; 70(13):5399-408. PubMed ID: 20530678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal syndecan-2 domain selectively enhances 6-O heparan sulfate chains sulfation and promotes VEGFA
    Corti F; Wang Y; Rhodes JM; Atri D; Archer-Hartmann S; Zhang J; Zhuang ZW; Chen D; Wang T; Wang Z; Azadi P; Simons M
    Nat Commun; 2019 Apr; 10(1):1562. PubMed ID: 30952866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syndecan-2 affects the basal and chemotherapy-induced apoptosis in osteosarcoma.
    Orosco A; Fromigué O; Bazille C; Entz-Werle N; Levillain P; Marie PJ; Modrowski D
    Cancer Res; 2007 Apr; 67(8):3708-15. PubMed ID: 17440083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focal adhesion kinase regulates syndecan-2-mediated tumorigenic activity of HT1080 fibrosarcoma cells.
    Park H; Han I; Kwon HJ; Oh ES
    Cancer Res; 2005 Nov; 65(21):9899-905. PubMed ID: 16267014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization, expression profiles of the porcine SDC2 and HSPG2 genes and their association with hematologic parameters.
    Wang W; Tao C; Zhou P; Zhou X; Zhang Q; Liu B
    Mol Biol Rep; 2013 Mar; 40(3):2549-56. PubMed ID: 23264070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The extracellular domain of syndecan-2 regulates the interaction of HCT116 human colon carcinoma cells with fibronectin.
    Kwon MJ; Kim Y; Choi Y; Kim SH; Park S; Han I; Kang DH; Oh ES
    Biochem Biophys Res Commun; 2013 Feb; 431(3):415-20. PubMed ID: 23333331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syndecan-2 cytoplasmic domain regulates colon cancer cell migration via interaction with syntenin-1.
    Lee H; Kim Y; Choi Y; Choi S; Hong E; Oh ES
    Biochem Biophys Res Commun; 2011 May; 409(1):148-53. PubMed ID: 21569759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of heparins and nano-heparins as therapeutic tool in breast cancer.
    Afratis NA; Karamanou K; Piperigkou Z; Vynios DH; Theocharis AD
    Glycoconj J; 2017 Jun; 34(3):299-307. PubMed ID: 27778131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syndecan-2 downregulation impairs angiogenesis in human microvascular endothelial cells.
    Noguer O; Villena J; Lorita J; Vilaró S; Reina M
    Exp Cell Res; 2009 Mar; 315(5):795-808. PubMed ID: 19073173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syndecan-2 functions as a docking receptor for pro-matrix metalloproteinase-7 in human colon cancer cells.
    Ryu HY; Lee J; Yang S; Park H; Choi S; Jung KC; Lee ST; Seong JK; Han IO; Oh ES
    J Biol Chem; 2009 Dec; 284(51):35692-701. PubMed ID: 19858218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postsynaptic SDC2 induces transsynaptic signaling via FGF22 for bidirectional synaptic formation.
    Hu HT; Umemori H; Hsueh YP
    Sci Rep; 2016 Sep; 6():33592. PubMed ID: 27627962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extra-embryonic syndecan 2 regulates organ primordia migration and fibrillogenesis throughout the zebrafish embryo.
    Arrington CB; Yost HJ
    Development; 2009 Sep; 136(18):3143-52. PubMed ID: 19700618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of syndecan-1 overexpression on mesenchymal tumour cell proliferation with focus on different functional domains.
    Zong F; Fthenou E; Castro J; Péterfia B; Kovalszky I; Szilák L; Tzanakakis G; Dobra K
    Cell Prolif; 2010 Feb; 43(1):29-40. PubMed ID: 19840029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syndecan-2 regulation of morphology in breast carcinoma cells is dependent on RhoGTPases.
    Lim HC; Couchman JR
    Biochim Biophys Acta; 2014 Aug; 1840(8):2482-90. PubMed ID: 24447566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Participation of syndecan 2 in the induction of stress fiber formation in cooperation with integrin alpha5beta1: structural characteristics of heparan sulfate chains with avidity to COOH-terminal heparin-binding domain of fibronectin.
    Kusano Y; Oguri K; Nagayasu Y; Munesue S; Ishihara M; Saiki I; Yonekura H; Yamamoto H; Okayama M
    Exp Cell Res; 2000 May; 256(2):434-44. PubMed ID: 10772816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.